![DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas - ScienceDirect DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2372770521001893-fx1.jpg)
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas - ScienceDirect
![Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis](https://www.frontiersin.org/files/Articles/665718/fimmu-12-665718-HTML/image_m/fimmu-12-665718-g001.jpg)
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Gruppo San Donato - ANTICORPI ANTI VIRUS EPSTEIN-BARR (EBV): QUALI TEST? Sono disponibili molti test in grado di rilevare i differenti tipi e classi di anticorpi diretti contro EBV. “Gli anticorpi, ci
![Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/3d5690df-0de6-493c-8788-cf4d81073686/gr1_lrg.jpg)